"Sources Sought Notice-Multiple Award IDIQ Construction Contract (FNLCR)
Cancelled Special Notice Posted
- Agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 236220 Commercial and Institutional Building Construction
- Place of performance
- Frederick, Maryland, United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The National Cancer Institute, on behalf of Leidos Biomedical Research, Inc., issued a sources sought notice on August 5, 2026, for an Indefinite Delivery/Indefinite Quantity subcontract for construction services at Frederick National Laboratory for Cancer Research; capability statements are due September 18, 2026, at 4:00 p.m. The work falls under NAICS 236220 (commercial and institutional building construction) and is not set-aside. Leidos Biomed operates FNLCR under prime contract 75N91019D00024 issued by the National Cancer Institute at the National Institutes of Health in Frederick, Maryland. Prospective offerors must submit capability statements by the deadline; the notice will automatically archive 600 days after the response date. Interested vendors cannot add or remove themselves from or view the interested vendors list. Matthew Hull, Contracts Manager at matthew.hull@nih.gov or 301-846-6998, serves as the primary point of contact. Additional information is available at https://frederick.cancer.gov/work-us/vendors-subcontractors/business-opportunities/multiple-award-idiq-construction-contract-fnlcr.
Notice text
National Institutes of Health, National Cancer Institute, Frederick National Laboratory for Cancer Research Opportunities-Special Announcements:
Frederick National Laboratory for Cancer Research (FNLCR) Operated by Leidos Biomedical Research, Inc. (Leidos Biomed) for the National Cancer Institute requires an Indefinite Delivery/Indefinite Quantity Subcontract for construction services for the Frederick National Laboratory for Cancer Research (FNLCR).
For information concerning opportunities with the FNLCR, please refer to:
https://frederick.cancer.gov/work-us/vendors-subcontractors/business-opportunities/multiple-award-idiq-construction-contract-fnlcr
or contact the Leidos Biomedical Research Point of Contact listed in this announcement.
Background Information: Leidos Biomedical Research, Inc. (Leidos Biomed), a subsidiary of Leidos Corporation, a Delaware corporation with offices in Frederick, MD is the Operations and Technical Support (OTS) contractor for the National Cancer Institute at Frederick. The effort to be performed will be part of Leidos Biomed’s Prime Contract 75N91019D00024 that has been issued by the National Cancer Institute, National Institutes of Health, Frederick, MD.
Leidos Biomedical Research, Inc. POC: Contracts Manager at matthew.hull@nih.gov
Files
| File | Type | Posted |
|---|---|---|
| SAM Request (Sources Sought - Constr. IDIQ.pdf |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| NCI OA Special Notice of Subcontract Opportunity at the Frederick National Laboratory for Cancer Research” | National Cancer Institute | No set-aside | |
| Construction Contract Sources Sought | National Nuclear Security Administration | No set-aside | |
| FDA Lab Renovation in Silver Spring, MD | — | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity